Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Exciting Developments Unveiled: A Deep Dive into Spectral's

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Dec 20, 2023 1:56pm

168 Views

Post# 35794197

RE:RE:RE:RE:RE:Exciting Developments Unveiled: A Deep Dive into Spectral's

Baxter may want to get a foothold in the other 2000 ICU's ( that presumably don't have any Prism CRTs ) by purchasing the NA rights to the SAMI which as I recall is FDA approved to be used in HP.

For that matter it might also position them to tackle the coming paradigm shift in Home Kidney care ( a stated mandate of theirs) ala the DIMI.

Don't shoot the messenger. I'm just an idea generator ;)

MM